Apart from being recurrently mutated in rCLL, SAMHD1 mutations were also found in 18% of patients with T-cell prolymphocytic leukemia (T-PLL) [22]. This evidence concerns the gene SAMHD1 and T-cell prolymphocytic leukemia.